Home › Funds › Diesslin Group, Inc. › NVS
Diesslin Group, Inc. position in NVS
NOVARTIS AG · Health Care
Diesslin Group, Inc. reported holding 5,434 shares of NVS (NOVARTIS AG) in its Q3 2026 13F filing — a position valued at US$775K, representing 0.30% of its reported portfolio and ranking #24 among its reported holdings. Diesslin Group, Inc. has disclosed NVS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR
How Diesslin Group, Inc.'s NVS position evolved
Diesslin Group, Inc. first disclosed a stake in NVS in Q4 2025 at 5,434 shares (US$749K). The position peaked in Q2 2026 at 5,434 shares, worth US$852K. Across 4 filings, Diesslin Group, Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 5,434 shares valued at US$775K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 5.43K | $749.24K | New |
| Q1 2026 | 5.43K | $830.11K | Hold |
| Q2 2026 | 5.43K | $851.68K | Hold |
| Q3 2026 | 5.43K | $774.78K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVS and 13F data
NVS (NOVARTIS AG) is a Health Care company. 24 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.43B), PRIMECAP MANAGEMENT CO/CA/ (US$1.03B), LOOMIS SAYLES & CO L P (US$821.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVS
- Fisher Asset Management, LLC 15.52M sh · $2.43B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 6.59M sh · $1.03B · Q2 2026
- LOOMIS SAYLES & CO L P 5.24M sh · $821.10M · Q2 2026
- NATIXIS ADVISORS, LLC 2.39M sh · $374.02M · Q2 2026
- GQG Partners LLC 2.15M sh · $337.13M · Q2 2026
- Cullen Capital Management, LLC 2.03M sh · $318.62M · Q2 2026
- WCM INVESTMENT MANAGEMENT, LLC 1.90M sh · $300.11M · Q2 2026
More on Diesslin Group, Inc.
FAQ
How long has Diesslin Group, Inc. held NVS?
Diesslin Group, Inc. has disclosed NVS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Diesslin Group, Inc.'s current position in NVS?
As of Q3 2026, Diesslin Group, Inc. holds 5.43K shares of NVS (NOVARTIS AG), valued at $774.78K, representing 0.30% of its reported portfolio and ranking #24.
Has Diesslin Group, Inc. been buying or selling NVS?
In the latest 13F filing (Q3 2026), Diesslin Group, Inc. held unchanged its position in NVS. The position peaked in Q2 2026 at 5.43K shares.
Which other funds hold NVS?
Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.